Element Biosciences
PrivateLast Round
Series E
Jun 9, 2026
Est. Valuation
$1.03B
Total Funding Raised
$888.41M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Element Biosciences is a biotechnology company that develops modular and high-performing DNA sequencing platforms designed to enhance research and diagnostics by providing quality data and workflow flexibility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery, Computing Hardware
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Element Biosciences Comparables
Compare Element Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ultima Genomics | 87% | |
| Singular Genomics | 84% | |
| Axbio | 81% | |
Element Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 9, 2026 | ||||
| Series D | Jul 11, 2024 | ||||
| Series C | Jun 29, 2021 | ||||
| Series B Extension | Jun 26, 2020 | ||||
| Series B | Jan 9, 2020 | ||||
Series A | Jun 18, 2019 |
Key People
Founding team and executive leadership
Element Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C |
| RA Capital Management | Series B Extension, Series B, Series C |
| Fusion Fund | Series D |
| Fidelity Management & Research Company | Series D, Series C, Series B |
| Fidelity Investments | Series D |
| Morgan Stanley | Series C |
| Logos Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
$175M round led by Samsung Electronics
- Apr 23, 2026
Achieved compliance with ISO 27001, ISO 9001, and ISO 13485 standards.
Element Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Element Biosciences's valuation, stock price, and market status.